-The Times of India NEW DELHI: With an aim to ensure women’s hygiene, the government has slashed price of sanitary napkins sold at Jan Aushadhi stores to just Re 1 per piece from Rs 2.50. The biodegradable napkins - available in a pack of four - will be sold at a subsidized price under the brand 'Suvidha' at 5,500 such stores across the country. The move assumes significance as many women, especially...
More »SEARCH RESULT
Total Matching Records found : 232
Explained: What is Rajasthan's free medicine scheme -Hamza Khan
-The Indian Express Dr Manoj Thaguria said, “A lot of patients revisit the dispensaries, hence the high number of beneficiaries. Some also manage to get a second course of prescribed medicines on the same day." Jaipur: In his budget address earlier this week, Rajasthan Chief Minister Ashok Gehlot increased the number of free medicines from 608 to 712 and free tests from 70 to 90, under the Chief Minister’s Free Medicine...
More »India trashes US report, calls it attack on cheap generic drugs -Sushmi Dey
-The Times of India NEW DELHI: India has outrightly rejected allegations in a US report about the country being a chief source of counterfeit medicines to the world and said it is an attack on low cost generic drugs — crucial to make healthcare affordable. The ‘Special 301 Report’ by United States Trade Representative (USTR) slammed India and China as leading sources of counterfeit medicines distributed globally with 20% of all pharmaceutical...
More »Many essential drugs priced much higher than manufacturing cost: WHO -Sushmi Dey
-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »To shield patents, firms seek information on generic drug launches -Sushmi Dey
-The Times of India NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval. The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking...
More »
